Entero Healthcare Solutions Ltd's Q4FY25 Quarter Results
- 28 May 2025
Result Summary
- Entero Healthcare Solutions Ltd reported a 23.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 17.5%.
- Its expenses for the quarter were down by 22.4% QoQ and up 16.1% YoY.
- The net profit decreased 28.1% QoQ and decreased 654.5% YoY.
- The earnings per share (EPS) of Entero Healthcare Solutions Ltd stood at 5.7 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 1043.32 | 1366.49 | 887.80 | -23.6% | 17.5% |
Total Expenses | 1029.76 | 1327.05 | 886.81 | -22.4% | 16.1% |
Profit Before Tax | 13.56 | 39.44 | 0.98 | -65.6% | 1283.7% |
Tax | -7.62 | 9.99 | 4.80 | -176.3% | -258.8% |
Profit After Tax | 21.18 | 29.45 | -3.82 | -28.1% | -654.5% |
Earnings Per Share | 5.70 | 5.80 | 0.00 | -1.7% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Entero Healthcare Solutions Ltd is a company operating in the healthcare industry, primarily engaged in providing healthcare solutions. While specific details about the company's main products or services are not provided, companies in this sector typically deal with a range of medical products, pharmaceutical distribution, and healthcare services. As of October 2023, there are no specific recent major developments available for Entero Healthcare Solutions Ltd. The company appears to focus on delivering value through an integrated approach to healthcare, supporting patient care with quality products and solutions.
Revenue
During the fourth quarter of fiscal year 2025 (Q4FY25), Entero Healthcare Solutions Ltd reported a total income of ₹1043.32 crores. This represents a quarter-over-quarter (QoQ) decline of 23.6% compared to the previous quarter (Q3FY25), which posted total income of ₹1366.49 crores. However, on a year-over-year (YoY) basis, total income increased by 17.5% from ₹887.80 crores in Q4FY24. These figures reflect the company's revenue-generating activities over the period and highlight the fluctuations in income generation between quarters and years.
Profitability
The profitability of Entero Healthcare Solutions Ltd in Q4FY25 shows a Profit Before Tax (PBT) of ₹13.56 crores. This marks a significant decrease of 65.6% QoQ from Q3FY25, where the PBT was ₹39.44 crores. Nonetheless, on a YoY basis, there is a substantial increase of 1283.7% from the PBT of ₹0.98 crores in Q4FY24. The company's Profit After Tax (PAT) for Q4FY25 is ₹21.18 crores, down 28.1% QoQ from ₹29.45 crores in the previous quarter, but substantially up from a negative PAT of ₹-3.82 crores in Q4FY24, indicating a turnaround in profitability. The Earnings Per Share (EPS) for Q4FY25 is recorded at ₹5.70, showing a slight decrease of 1.7% QoQ from Q3FY25's EPS of ₹5.80.
Operating Metrics
In Q4FY25, Entero Healthcare Solutions Ltd incurred total expenses of ₹1029.76 crores, which is a 22.4% decrease QoQ from ₹1327.05 crores in Q3FY25. On a YoY basis, total expenses increased by 16.1% from ₹886.81 crores in Q4FY24. The tax expense for Q4FY25 is reported as negative, amounting to ₹-7.62 crores, indicating a reversal or credit, compared to a tax expense of ₹9.99 crores in Q3FY25 and ₹4.80 crores in Q4FY24. These metrics capture the company's operational expenditures and tax obligations, illustrating the changes in operating costs and fiscal responsibilities over time.